|
|
 |
 |
|  |  |
 |  |  |  |  |
organism-gene
 |


|
 PR:P10646 |
   tissue factor pathway inhibitor (human)
 |
   hTFPI
 |
  "A tissue factor pathway inhibitor that is encoded in the genome of human." [PRO:DNx, UniProtKB:P10646]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:P10646-1 |
   tissue factor pathway inhibitor isoform Alpha (human)
 |
   hTFPI/iso:Alpha
 |
  "A tissue factor pathway inhibitor (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P10646-1." [PRO:DNx, UniProtKB:P10646]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:P10646-2 |
   tissue factor pathway inhibitor isoform Beta (human)
 |
   hTFPI/iso:Beta
 |
  "A tissue factor pathway inhibitor (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P10646-2." [PRO:DNx, UniProtKB:P10646]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000049428 |
   tissue factor pathway inhibitor, signal peptide removed form (human)
 |
   hTFPI/SigPep-
 |
  "A tissue factor pathway inhibitor (human) that has had the signal peptide removed. UniProtKB:P10646, 29-304." [PRO:DNx, Reactome:R-HSA-140827, Reactome:R-HSA-140832]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000054774 |
   tissue factor pathway inhibitor N-glycosylated 1 (human)
 |
   hTFPI/NGlyco:1
 |
  "A tissue factor pathway inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-145 of the amino acid sequence represented by UniProtKB:P10646-1, in which the glycan structure is represented by GlyTouCan:G07947TY. Example: UniProtKB:P10646-1, Asn-145, MOD:00160~GNO:G07947TY." [GlyGen:P10646-1, PMID:1388166, PMID:8639592, PRO:DNx]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000054775 |
   tissue factor pathway inhibitor N-glycosylated 2 (human)
 |
   hTFPI/NGlyco:2
 |
  "A tissue factor pathway inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-145 of the amino acid sequence represented by UniProtKB:P10646-1, in which the glycan structure is represented by GlyTouCan:G31991IV. Example: UniProtKB:P10646-1, Asn-145, MOD:00160~GNO:G31991IV." [GlyGen:P10646-1, PMID:1388166, PMID:8639592, PRO:DNx]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000054776 |
   tissue factor pathway inhibitor N-glycosylated 3 (human)
 |
   hTFPI/NGlyco:3
 |
  "A tissue factor pathway inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-145 of the amino acid sequence represented by UniProtKB:P10646-1, in which the glycan structure is represented by GlyTouCan:G45359RY. Example: UniProtKB:P10646-1, Asn-145, MOD:00160~GNO:G45359RY." [GlyGen:P10646-1, PMID:1388166, PMID:8639592, PRO:DNx]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000054777 |
   tissue factor pathway inhibitor N-glycosylated 4 (human)
 |
   hTFPI/NGlyco:4
 |
  "A tissue factor pathway inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-145 of the amino acid sequence represented by UniProtKB:P10646-1, in which the glycan structure is represented by GlyTouCan:G51562OR. Example: UniProtKB:P10646-1, Asn-145, MOD:00160~GNO:G51562OR." [GlyGen:P10646-1, PMID:1388166, PMID:8639592, PRO:DNx]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000054778 |
   tissue factor pathway inhibitor N-glycosylated 5 (human)
 |
   hTFPI/NGlyco:5
 |
  "A tissue factor pathway inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-145 of the amino acid sequence represented by UniProtKB:P10646-1, in which the glycan structure is represented by GlyTouCan:G63889NK. Example: UniProtKB:P10646-1, Asn-145, MOD:00160~GNO:G63889NK." [GlyGen:P10646-1, PMID:1388166, PMID:8639592, PRO:DNx]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000054779 |
   tissue factor pathway inhibitor N-glycosylated 6 (human)
 |
   hTFPI/NGlyco:6
 |
  "A tissue factor pathway inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-145 of the amino acid sequence represented by UniProtKB:P10646-1, in which the glycan structure is represented by GlyTouCan:G65832JS. Example: UniProtKB:P10646-1, Asn-145, MOD:00160~GNO:G65832JS." [GlyGen:P10646-1, PMID:1388166, PMID:8639592, PRO:DNx]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000054780 |
   tissue factor pathway inhibitor N-glycosylated 7 (human)
 |
   hTFPI/NGlyco:7
 |
  "A tissue factor pathway inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-145 of the amino acid sequence represented by UniProtKB:P10646-1, in which the glycan structure is represented by GlyTouCan:G78059CC. Example: UniProtKB:P10646-1, Asn-145, MOD:00160~GNO:G78059CC." [GlyGen:P10646-1, PMID:1388166, PMID:8639592, PRO:DNx]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000054781 |
   tissue factor pathway inhibitor N-glycosylated 8 (human)
 |
   hTFPI/NGlyco:8
 |
  "A tissue factor pathway inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-145 of the amino acid sequence represented by UniProtKB:P10646-1, in which the glycan structure is represented by GlyTouCan:G86357DX. Example: UniProtKB:P10646-1, Asn-145, MOD:00160~GNO:G86357DX." [GlyGen:P10646-1, PMID:1388166, PMID:8639592, PRO:DNx]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000054782 |
   tissue factor pathway inhibitor N-glycosylated 9 (human)
 |
   hTFPI/NGlyco:9
 |
  "A tissue factor pathway inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-195 of the amino acid sequence represented by UniProtKB:P10646-1, in which the glycan structure is represented by GlyTouCan:G07947TY. Example: UniProtKB:P10646-1, Asn-195, MOD:00160~GNO:G07947TY." [GlyGen:P10646-1, PMID:1388166, PMID:8639592, PRO:DNx]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000054783 |
   tissue factor pathway inhibitor N-glycosylated 10 (human)
 |
   hTFPI/NGlyco:10
 |
  "A tissue factor pathway inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-195 of the amino acid sequence represented by UniProtKB:P10646-1, in which the glycan structure is represented by GlyTouCan:G31991IV. Example: UniProtKB:P10646-1, Asn-195, MOD:00160~GNO:G31991IV." [GlyGen:P10646-1, PMID:1388166, PMID:8639592, PRO:DNx]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000054784 |
   tissue factor pathway inhibitor N-glycosylated 11 (human)
 |
   hTFPI/NGlyco:11
 |
  "A tissue factor pathway inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-195 of the amino acid sequence represented by UniProtKB:P10646-1, in which the glycan structure is represented by GlyTouCan:G45359RY. Example: UniProtKB:P10646-1, Asn-195, MOD:00160~GNO:G45359RY." [GlyGen:P10646-1, PMID:1388166, PMID:8639592, PRO:DNx]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000054785 |
   tissue factor pathway inhibitor N-glycosylated 12 (human)
 |
   hTFPI/NGlyco:12
 |
  "A tissue factor pathway inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-195 of the amino acid sequence represented by UniProtKB:P10646-1, in which the glycan structure is represented by GlyTouCan:G51562OR. Example: UniProtKB:P10646-1, Asn-195, MOD:00160~GNO:G51562OR." [GlyGen:P10646-1, PMID:1388166, PMID:8639592, PRO:DNx]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000054786 |
   tissue factor pathway inhibitor N-glycosylated 13 (human)
 |
   hTFPI/NGlyco:13
 |
  "A tissue factor pathway inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-195 of the amino acid sequence represented by UniProtKB:P10646-1, in which the glycan structure is represented by GlyTouCan:G63889NK. Example: UniProtKB:P10646-1, Asn-195, MOD:00160~GNO:G63889NK." [GlyGen:P10646-1, PMID:1388166, PMID:8639592, PRO:DNx]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000054787 |
   tissue factor pathway inhibitor N-glycosylated 14 (human)
 |
   hTFPI/NGlyco:14
 |
  "A tissue factor pathway inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-195 of the amino acid sequence represented by UniProtKB:P10646-1, in which the glycan structure is represented by GlyTouCan:G65832JS. Example: UniProtKB:P10646-1, Asn-195, MOD:00160~GNO:G65832JS." [GlyGen:P10646-1, PMID:1388166, PMID:8639592, PRO:DNx]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000054788 |
   tissue factor pathway inhibitor N-glycosylated 15 (human)
 |
   hTFPI/NGlyco:15
 |
  "A tissue factor pathway inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-195 of the amino acid sequence represented by UniProtKB:P10646-1, in which the glycan structure is represented by GlyTouCan:G78059CC. Example: UniProtKB:P10646-1, Asn-195, MOD:00160~GNO:G78059CC." [GlyGen:P10646-1, PMID:1388166, PMID:8639592, PRO:DNx]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000054789 |
   tissue factor pathway inhibitor N-glycosylated 16 (human)
 |
   hTFPI/NGlyco:16
 |
  "A tissue factor pathway inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-195 of the amino acid sequence represented by UniProtKB:P10646-1, in which the glycan structure is represented by GlyTouCan:G86357DX. Example: UniProtKB:P10646-1, Asn-195, MOD:00160~GNO:G86357DX." [GlyGen:P10646-1, PMID:1388166, PMID:8639592, PRO:DNx]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000054790 |
   tissue factor pathway inhibitor O-glycosylated 1 (human)
 |
   hTFPI/OGlyco:1
 |
  "A tissue factor pathway inhibitor (human) that has been O-glycosylated at the residue equivalent to Thr-203 of the amino acid sequence represented by UniProtKB:P10646-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:P10646-1, Thr-203, MOD:00005~GNO:G29068FM." [GlyGen:P10646-1, PMID:30459171, PRO:DNx]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000054791 |
   tissue factor pathway inhibitor O-glycosylated 2 (human)
 |
   hTFPI/OGlyco:2
 |
  "A tissue factor pathway inhibitor (human) that has been O-glycosylated at the residue equivalent to Thr-203 of the amino acid sequence represented by UniProtKB:P10646-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P10646-1, Thr-203, MOD:00005~GNO:G43417UB." [GlyGen:P10646-1, PMID:30459171, PRO:DNx]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000054792 |
   tissue factor pathway inhibitor O-glycosylated 3 (human)
 |
   hTFPI/OGlyco:3
 |
  "A tissue factor pathway inhibitor (human) that has been O-glycosylated at the residue equivalent to Thr-42 of the amino acid sequence represented by UniProtKB:P10646-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P10646-1, Thr-42, MOD:00005~GNO:G43417UB." [GlyGen:P10646-1, PMID:30459171, PRO:DNx]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000073933 |
   tissue factor pathway inhibitor cysteinylated 1 (human)
 |
   hTFPI/Cyst:1
 |
  "A tissue factor pathway inhibitor (human) that has been cysteinylated on the residue at the position equivalent to Cys-100 of the amino acid sequence represented by UniProtKB:P10646-1. Example: UniProtKB:P10646-1, Cys-100, MOD:00765." [IEDB_epitope:2119355, IEDB_epitope:2121036, PRO:DNx]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000078121 |
   tissue factor pathway inhibitor cysteinylated 2 (human)
 |
   hTFPI/Cyst:2
 |
  "A tissue factor pathway inhibitor (human) that has been cysteinylated on the residue at the position equivalent to Cys-54 of the amino acid sequence represented by UniProtKB:P10646-1. Example: UniProtKB:P10646-1, Cys-54, MOD:00765." [IEDB_epitope:2124375, PRO:DNx]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000083682 |
   tissue factor pathway inhibitor cysteinylated 3 (human)
 |
   hTFPI/Cyst:3
 |
  "A tissue factor pathway inhibitor (human) that has been cysteinylated on the residue at the position equivalent to Cys-134 of the amino acid sequence represented by UniProtKB:P10646-1. Example: UniProtKB:P10646-1, Cys-134, MOD:00765." [IEDB_epitope:1331523, PRO:DNx]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000085075 |
   tissue factor pathway inhibitor phosphorylated 1 (human)
 |
   hTFPI/Phos:1
 |
  "A tissue factor pathway inhibitor (human) that has been phosphorylated on the residue at the position equivalent to Ser-30 of the amino acid sequence represented by UniProtKB:P10646-1. Example: UniProtKB:P10646-1, Ser-30, MOD:00046." [IEDB_epitope:920031, PRO:DNx]
 |

| 
|
|
|
|